SpringerLink
Log in

Labetalol and hypoglycaemia unawareness: two case reports and considerations about its use as an antihypertensive drug for women with diabetes and pregnancy

  • Case Report
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fagerholm V, Haaparanta M, Scheinin M (2011) Α 2-Adrenoceptor regulation of blood glucose homeostasis. Basic Clin Pharmacol Toxicol 108(6):365–370. https://doi.org/10.1111/j.1742-7843.2011.00699.x

    Article  CAS  PubMed  Google Scholar 

  2. Pathak RD, Schroeder EB, Seaquist ER et al (2016) Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in US integrated health care delivery systems. Diabetes Care 39(3):363–370

    Article  CAS  Google Scholar 

  3. Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER (2012) Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabet Med 29(5):558–566. https://doi.org/10.1111/j.1464-5491.2012.03604.x

    Article  CAS  PubMed  Google Scholar 

  4. National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management (NICE guideline NG133). https://www.nice.org.uk/guidance/ng133

  5. FDA Summary of Product Characteristics (SMPC), Labetalol. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018716s026lbl.pdf.

Download references

Acknowledgements

We want to thank the patients for approving the report of their experiences.

Funding

None.

Author information

Authors and Affiliations

  1. Endocrinology and Nutrition Department, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain

    M. Mateu-Salat & R. Corcoy

  2. Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain

    R. Corcoy

  3. CIBER-BBN, Barcelona, Spain

    R. Corcoy

Authors
  1. M. Mateu-Salat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Corcoy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Corcoy.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest in relation to this article.

Informed consent

Signed consent was obtained from both patients.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article belongs to the topical collection Pregnancy and Diabetes, managed by Antonio Secchi and Marina Scavini.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mateu-Salat, M., Corcoy, R. Labetalol and hypoglycaemia unawareness: two case reports and considerations about its use as an antihypertensive drug for women with diabetes and pregnancy. Acta Diabetol 58, 817–818 (2021). https://doi.org/10.1007/s00592-021-01688-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-021-01688-9

Keywords

Search

Navigation